Osteoporosis clinical trials
26 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Effect of Acetylcholinesterase Inhibitors on Bone Metabolism
- Combined Anabolic Therapy
- Preserving Geriatric Muscle With an Osteoporosis Medication
- RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
- Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal Females
- OsteoPorotic fracTure preventION System (OPTIONS) Research Study
- Prunes Preventing Bone Loss in Perimenopause
- Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
- Mode of Exercise and Bone Biomarkers in Older Veterans
- The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures
- Genetic Regulators of Bone Health That Are Unique to Vertebral Bone
- Precision Medicine Approaches to Renal Osteodystrophy
- Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
- Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
- A Natural History Study of Bone and Mineral Disorders
- Synbiotic to Attenuate Resorption of the Skeleton
- Mechanisms of Anabolic Osteoporosis Therapy
- U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures
- Studying Patient Experiences in Osteoporosis Clinical Trials
- The Effect of Osteoporotic Medications on Vertebral Bone Quality Score
- Contribution of Bone to Urine Citrate
- Precision Medicine Approach for Osteoporosis - Follow Up Study
- Prevention of Injury in Skilled Nursing Facilities Through Optimizing Medications
- Persona SoluTion PPS Femur PMCF
- Quest to Analyze One Thousand Humans Meditating
- Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Osteoporosis” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.